What Analysts Are Saying Most analysts lowered their price targets on the stock following the release, but remain moderately optimistic about the drugs potential if dosing is fixed: Piper Sandler cut its target from $20 to $13, noting that the 200 mg dose was clearly suboptimal but that the drugs clean safety and synergy with Wegovy are encouraging
From 0.50mg to 1.0mg means doubling again to 40 units
Research on GLP-1 therapy discontinuation suggests that certain metabolic improvements show partial persistence even after weight regain
Whether youre topping up or trying MT2 for the first time, weve got you covered with quality you can trust
[DOI] [PubMed] [Google Scholar] 31.Taub D.D., Tsarfaty G., Lloyd A.R., Durum S.K., Longo D.L., Murphy W.J
Protocol cycling decisions, including continuous vs paused, are determined at the consultation based on IGF-1 response and treatment goals